Full Text View
Tabular View
No Study Results Posted
Related Studies
Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics (HEARTWORK)
This study has been terminated.
Study NCT01065051   Information provided by Bayer

First Received on February 8, 2010.   Last Updated on June 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension, Pulmonary
Ventricular Dysfunction, Left
Additional conditions recognized in this trial
Hypertension
Ventricular Dysfunction
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Riociguat (BAY63-2521)
Placebo
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services